Advertisement
Canada markets open in 6 hours 57 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7256
    -0.0008 (-0.11%)
     

  • CRUDE OIL

    83.87
    +1.14 (+1.38%)
     

  • Bitcoin CAD

    85,668.34
    +1,364.19 (+1.62%)
     

  • CMC Crypto 200

    1,281.18
    -31.44 (-2.40%)
     

  • GOLD FUTURES

    2,396.10
    -1.90 (-0.08%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,409.75
    -137.50 (-0.78%)
     

  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     

  • FTSE

    7,877.05
    +29.06 (+0.37%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6819
    -0.0002 (-0.03%)
     

Hamilton Thorne to Announce Q1 2020 Financial Results on May 28 and Hold Conference Call on May 29, 2020

GlobeNewswire

BEVERLY, Mass. and TORONTO, May 26, 2020 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (HTL.V), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three-month period ended March 31, 2020 after market close on Thursday, May 28, 2020. The press release, with accompanying financial information, will be posted on the Company’s website at www.hamiltonthorne.ltd and on www.sedar.com.

The Company will follow with a conference call on Friday, May 29, 2020 at 11:00 a.m. EDT to review highlights of the results. All interested parties are welcome to join the conference call by dialing toll free 1-855-223-7309 in North America, or 647-788-4929 from other locations, and requesting Conference ID 29985315. A recording of the call will be available on Hamilton Thorne’s website shortly after the call.

About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)

Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

ADVERTISEMENT

Neither the TSX Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

David Wolf, President & CEO

Michael Bruns, CFO

Hamilton Thorne Ltd.

Hamilton Thorne Ltd.

978-921-2050

978-921-2050

ir@hamiltonthorne.ltd

ir@hamiltonthorne.ltd

Glen Akselrod

Bristol Investor Relations

905-326-1888

glen@bristolir.com